AMCP Partnership Forum: Biosimilars—policy, practice, and postmarketing surveillance to support treatment and coverage decisions

AMCP Partnership Forum: Biosimilars—policy, practice, and postmarketing surveillance to support treatment and coverage decisions

With the dual goals of identifying key actions that can support the further development and use of biosimilars in the United States and providing consistent and accurate messages about the value of biosimilars, AMCP held a virtual multidisciplinary stakeholder forum December 15-16, 2020. The partici...

Full description

Bibliographic Details
Main Author: Dharbhamalla, V. (Author)
Format: Article
Language:English
Published: Academy of Managed Care Pharmacy (AMCP) 2021
Subjects:
Article
biological therapy
biosimilar agent
Biosimilar Pharmaceuticals
clinical assessment
clinical decision making
clinical practice
Delivery of Health Care, Integrated
drug manufacture
economic aspect
economist
evidence based practice
Food and Drug Administration
health care policy
health care system
health economics
health insurance
Health Policy
human
Humans
insurance
Insurance Coverage
Insurance, Pharmaceutical Services
integrated health care system
law
pharmaceutical care
postmarketing surveillance
Product Surveillance, Postmarketing
reimbursement
United States
United States Food and Drug Administration
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items